secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-10-16T23:59:59+00:00
Accession:  0001213900-25-099560
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics closes $2.25M initial closing of Series E preferred stock financing, total $7M
--------------------------------------------------------------------------------

- Initial closing of 3,816 Series E preferred shares raised $2.25M gross proceeds on Oct 16, 2025.
- Amendment to SPA added an additional buyer and increased initial closing by $500k; total remains $7M.
- Series E preferred stock terms filed as Certificate of Designations on Oct 14, 2025.
- Remaining $4.75M to be funded at additional closings under the Securities Purchase Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025099560/0001213900-25-099560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025099560/ea0261237-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-099560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer